Correction to: The prevalence of cryptococcal antigen (CrAg) and benefits of pre-emptive antifungal treatment among HIV-infected persons with CD4+ T-cell counts < 200 cells/μL: evidence based on a meta-analysis
Main Authors: | Yao Li, Xiaojie Huang, Hui Chen, Yuanyuan Qin, Jianhua Hou, Aixin Li, Hao Wu, Xiaofeng Yan, Yaokai Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-06-01
|
Series: | BMC Infectious Diseases |
Online Access: | https://doi.org/10.1186/s12879-021-06132-5 |
Similar Items
-
The prevalence of cryptococcal antigen (CrAg) and benefits of pre-emptive antifungal treatment among HIV-infected persons with CD4+ T-cell counts < 200 cells/μL: evidence based on a meta-analysis
by: Yao Li, et al.
Published: (2020-06-01) -
Prevalence of cryptococcal antigen (CrAg) among HIV-positive patients in Eswatini, 2014–2015
by: Samson M. Haumba, et al.
Published: (2020-07-01) -
Violet Crag
by: Johnson, Joseph
Published: (2018) -
Establishing a cost-per-result of laboratory-based, reflex Cryptococcal antigenaemia screening (CrAg) in HIV+ patients with CD4 counts less than 100 cells/μl using a Lateral Flow Assay (LFA) at a typical busy CD4 laboratory in South Africa.
by: Naseem Cassim, et al.
Published: (2017-01-01) -
What Is the Most Appropriate Induction Regimen for the Treatment of HIV-Associated Cryptococcal Meningitis When the Recommended Regimen Is Not Available? Evidence From a Network Meta-Analysis
by: Yao Li, et al.
Published: (2020-06-01)